November 2024 - Page 2 of 12

TuesdayNov 26, 2024 8:45 am

Crypto Fest 2024: A Resounding Success in Cape Town, South Africa

The 6th edition of Crypto Fest returned on 11 October 2024, held at the iconic DHL Stadium in Cape Town, South Africa. The event brought together a vibrant mix of 403 attendees, 29 industry-leading speakers, and representatives from 16 countries, making it one of the most anticipated gatherings in the crypto and blockchain space. Hosted by Bitcoin Events, Crypto Fest 2024 offered a dynamic program filled with keynote addresses, panel discussions, educational workshops, and unparalleled networking opportunities. Key speakers included Richard de Sousa, CEO of AltCoinTrader, and Hannes Wessels, General Manager of Binance for Southern and Francophone Africa, who delivered…

TuesdayNov 26, 2024 8:40 am

QualityStocksNewsBreaks – Brera Holdings PLC (NASDAQ: BREA) Highlights Giuseppe Rossi’s Pepito Cup Revival and Community Impact

Brera Holdings (NASDAQ: BREA) announced the return of The Pepito Cup, an annual soccer fan club tournament organized by Advisory Board member Giuseppe Rossi. Held on November 17, 2024, at the Waldwick Superdome in New Jersey and sponsored by the GIUSEPPE ROSSI ACADEMY, the event featured 12 teams competing in a 25-minute match elimination format, with Napoli Club NYC crowned champions. Open to the public and family-friendly, the event reflects Brera Holdings' commitment to fostering community engagement and expanding its global sports footprint through initiatives led by influential figures like Rossi. To view the full press release, visit https://ibn.fm/NfRTX About…

TuesdayNov 26, 2024 8:00 am

EXECUTIVE REPORT: 4th INVESTIGATOR-INITIATED TRIALS SUMMIT

Dynamic Global Events (“DGE”) recently hosted the Investigator-Initiated Trials (“IIT”) Conference, gathering industry experts, clinical investigators and research professionals for an immersive two-day event focused on advancing investigator-initiated trials. This year’s event provided an in-depth look into the challenges, best practices and regulatory considerations essential to optimizing IIT processes in today’s rapidly evolving clinical research landscape. Highlights from the Conference The IIT Conference featured a dynamic lineup of speakers who shared their insights on topics critical to the success of IITs, including trial design, funding strategies and operational efficiency. Speakers from leading pharmaceutical companies, academic institutions and research organizations brought…

MondayNov 25, 2024 8:45 am

Kairos Pharma Ltd. (NYSE: KAPA) Developing Innovative Therapies to Tackle Cancer Drug Resistance, Immune Suppression

The company has an extensive IP portfolio, valid through 2040, and a drug pipeline in different preclinical and clinical stages, targeting cancer drug resistance and immune suppression. Kairos Pharma’s lead candidate ENV-105 is an antibody targeting CD105, a protein identified as a key driver of resistance to various cancer treatments. ENV-105 is in a Phase 2 trial for castrate-resistant prostate cancer (NCT05534646, in combination with Apalutamide) and a Phase 1 trial for EGFR-driven non-small cell lung cancer (NCT05401110, in combination with Osimertinib). The company is working with PreCheck Health Services to develop companion biomarkers for ENV-105, with the aim of…

MondayNov 25, 2024 8:30 am

SuperCom Ltd. (NASDAQ: SPCB) Conference Presentation Focuses on Lives Saved Through EM Technology and Services

SuperCom is an electronic monitoring (“EM”) innovator helping to establish public safety and well-being through the use of advanced technology and monitoring services for government clients that make increasing use of supervised-release programs During a recent investor presentation at the annual LD Micro Invitational, SuperCom’s president and CEO, Ordan Trabelsi, outlined the company’s services and critical benefits to clientele, along with the company’s corresponding success with over 50 governments and 100,000 individuals served SuperCom anticipates that its $32 million contract in Romania, largely focused on monitoring domestic violence offenders, will help boost its credibility with other European governments running monitoring…

MondayNov 25, 2024 8:25 am

QualityStocksNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Schedules Investor Webcast to Share Clinical and Strategic Updates

Annovis Bio (NYSE: ANVS), a clinical-stage company developing therapies for neurodegenerative diseases, will host a live investor webcast on Dec. 11, 2024, at 4:30 PM EST. Led by Founder and CEO Dr. Maria Maccecchini, the event will highlight updates on Phase 3 studies for Parkinson’s and Alzheimer’s diseases, regulatory milestones, financial strategies, and plans for advancing neurodegenerative therapies in 2025. To view the full press release, visit https://ibn.fm/2Ib9D About Annovis Bio Inc. Annovis Bio, headquartered in Malvern, Pennsylvania, is committed to addressing neurodegeneration in diseases such as Alzheimer’s and Parkinson’s. The company is developing innovative therapies that target multiple neurotoxic…

MondayNov 25, 2024 8:00 am

EXECUTIVE REPORT: 5TH NEXT-GEN MSL EXCELLENCE SUMMIT

Dynamic Global Events recently concluded the 5th Next-Gen MSL Excellence conference, a premier event that brought together MSLs, field medical professionals and industry thought leaders to explore the best ways to grow “soft skills” and maintain productive KOL relationships. This engaging event highlighted innovative strategies, skills development and cutting-edge technologies that are shaping the future of MSLs and their crucial role in bridging scientific knowledge with clinical practice. Key Takeaways from the Conference The conference featured an impressive lineup of speakers, offering invaluable insights on how MSLs can excel in their roles and adapt to industry trends. Leaders from top…

MondayNov 25, 2024 8:00 am

QualityStocksNewsBreaks – Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF) Updates 2024 Exploration Progress at Storm Copper Project, Highlights New Discoveries

Aston Bay (TSX.V: BAY) (OTCQB: ATBHF) provided an update on the 2024 exploration activities at the Storm Copper Project on Somerset Island, Nunavut, operated by American West Metals Limited under a 20/80 joint venture agreement. Aston Bay retains a free carried interest until a mining decision is made following a bankable feasibility study. CEO Thomas Ullrich highlighted the discovery of two new zones with copper, zinc, and silver mineralization, emphasizing the potential of the 110 km-long trend. He noted the success of prospecting, geophysics, geochemistry, and drilling efforts and announced ongoing development of a maiden resource and further testing of…

MondayNov 25, 2024 7:30 am

QualityStocksNewsBreaks – SuperCom Ltd. (NASDAQ: SPCB) Reports Strong Financial Performance and New Contracts, Expanding Footprint in US and Israel

SuperCom (NASDAQ: SPCB) reported a solid performance for Q3 2024, with year-to-date revenue reaching $21.3 million, a 2% increase over the prior year, and gross profit rising 35% to $10.7 million. Strategic contract wins, including a 5-year electronic monitoring project with Israel Prison Service and multiple U.S. contracts in states like West Virginia, Maryland, and New York, underscore SuperCom’s expanding presence in public safety and rehabilitative services. CEO Ordan Trabelsi highlighted SuperCom’s operational efficiency and growth potential, as demonstrated by improved profitability, positive free cash flow, and an increased gross profit margin. The company remains focused on innovation and deepening client…

Site Search

Company Search

Month: November 2024